Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DURVALUMAB Cause Multiple organ dysfunction syndrome? 71 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Multiple organ dysfunction syndrome have been filed in association with DURVALUMAB (IMFINZI). This represents 0.4% of all adverse event reports for DURVALUMAB.

71
Reports of Multiple organ dysfunction syndrome with DURVALUMAB
0.4%
of all DURVALUMAB reports
63
Deaths
39
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From DURVALUMAB?

Of the 71 reports, 63 (88.7%) resulted in death, 39 (54.9%) required hospitalization, and 20 (28.2%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DURVALUMAB. However, 71 reports have been filed with the FAERS database.

What Other Side Effects Does DURVALUMAB Cause?

Death (2,817) Malignant neoplasm progression (1,330) Pneumonitis (827) Radiation pneumonitis (786) Pyrexia (573) Diarrhoea (530) Pneumonia (453) Dyspnoea (444) Interstitial lung disease (430) Off label use (395)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which DURVALUMAB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

DURVALUMAB vs DUTASTERIDE DURVALUMAB vs DUTASTERIDE\TAMSULOSIN DURVALUMAB vs DUVELISIB DURVALUMAB vs DYDROGESTERONE DURVALUMAB vs EBASTINE

Related Pages

DURVALUMAB Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome DURVALUMAB Demographics